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Importance
Asthma morbidity and mortality have steadily
increased since the mid-1970s (1), possibly
reaching a plateau recently, but the causes of
this rise are largely unknown. The rise in
allergic rhinitis may have begun after the
inception of the industrial revolution (2). The
possibility of a linkage between the rise in
asthma and in allergic rhinitis is supported by
the consensus that the two diseases share cer-
tain genetic and environmental determinants
(3). During the time that asthma increased,
regulated ambient criteria air pollutants gen-
erally decreased in the United States. Because
the two time trends are not positively related,
arguably the rise in asthma could not be due
to exposure to ambient air pollutants. This
argument is not valid because correlations
between time series are subject to ecologic fal-
lacy. This biased interpretation can occur
when associations at an aggregate level do not
represent associations on an individual level
because of unrelated causal factors that inde-
pendently drive one or both of the aggregate
trends. The bias may be ampliﬁed if trends in
synergistic or antagonistic factors are ignored.
For example, a lifestyle risk factor or other
environmental exposure may have increased
over the same period, and that factor could
have positively interacted with effects of the
regulated air pollutants. Many factors associ-
ated with Western industrial life other than
environmental pollution have been identiﬁed
as potential causes for the asthma epidemic,
including allergens from indoor carpeting and
pets coupled with increases in indoor resi-
dence time and in building tightness, early
antibiotic use that prevents differentiation
toward T-helper type 1 lymphocytes (TH1),
declining physical ﬁtness, and diet (4). 
Acute asthma morbidity has been associ-
ated with specific regulated air pollutants in
aggregate time series and in individual-level
repeated measures studies [reviewed by
Bascom et al. (5)]. The risk of asthma onset
or chronic effects on asthma from ambient air
pollution exposure has been less clearly iden-
tiﬁed in epidemiologic studies, although few
studies are prospective cohort designs (6–13).
A cohort study of nonsmoking adult Seventh
Day Adventists in California followed 10 or
more years found associations between the
development of asthma and outdoor concen-
trations of total suspended particulates (11),
total suspended sulfate (12), and ozone (O3)
(13). The association for O3 was found in
males but not in females, possibly because
males in that study spent significantly more
time outdoors than females (13). Three
cohort studies looked at lung function growth
in children and found significant reductions
in growth of forced expiratory volume in 1 sec
(FEV1) and forced vital capacity (FVC) in
relation to increasing levels of ambient air pol-
lutants, including nitrogen dioxide (NO2),
particulate matter (PM) < 10 and < 2.5 µm in
aerodynamic diameter (PM10 and PM2.5,
respectively), O3, sulfur dioxide (SO2), and
black smoke (an indicator of soot, including
diesel exhaust [DE]) (8–10). Diminished lung
function growth is one of the possible adverse
outcomes of poorly controlled asthma (14). 
Epidemiologic studies of asthma and
ambient air pollution have focused primarily
on ﬁve of six principal criteria air pollutants
(excluding lead) for which the U.S.
Environmental Protection Agency (U.S.
EPA) has established so-called National
Ambient Air Quality Standards (NAAQS):
O3, PM, carbon monoxide (CO), NO2, and
SO2. Studies in Europe have also used black
smoke, which can represent sources of com-
plex exposures such as DE that have a high
elemental carbon content. The causal compo-
nents in the epidemiologic studies have not
been clearly identified, partly because the
measurements have included only those
major pollutant types that a) co-vary with
other photochemically produced pollutants
(e.g., O3 with aldehydes); b) involve complex
particle mixtures that vary by space and time
(e.g., black smoke, PM10, or PM2.5); or c) are
correlated with other cogenerated primary
pollutants (e.g., NO2 or SO2 with organic
compounds from fossil fuel combustion).
The availability of government monitoring
data and the regulatory focus partly explains
the lack of epidemiologic data concerning
other potentially important exposures such as
air toxics. Experimental research on the respi-
ratory effects of air toxics is largely limited to
animal models or in vitro studies. This is not
surprising given that many air toxics have
potentially serious adverse consequences such
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effects. The occupational literature, on the
other hand, has data on high exposures that
may be less frequently encountered in non-
occupational settings.
Given the lack of information on the
causal role in asthma of a large number of
potentially important air pollutants, it is
important at this stage to identify informa-
tion that future research can build upon. This
article provides a review of the literature rele-
vant to this issue. A major objective is to
establish conceptual linkages concerning
potential adverse respiratory effects of air tox-
ics between different foci of research, includ-
ing occupational, indoor, and community air
pollution research.
Overview of Asthma 
and Air Toxics
Air toxics can be deﬁned as having three char-
acteristics: a) they have the potential to cause
serious adverse health effects in the general
population or to organisms in the environ-
ment as a result of airborne exposures; b) they
are released from anthropogenic sources; and
c) they include 189 hazardous air pollutants
listed in section 112.b.1 of the Clean Air Act
of 1990. It is conceivable that personal expo-
sures to some air toxics (toxic air pollutants)
may have increased over the last several
decades and been partly responsible for the
increase in asthma. Most notably, the U.S.
Department of Transportation reports that
the number of ton-miles carried by intercity
trucks has steadily increased from 285 billion
ton-miles in 1960 to 1,027 billion ton-miles
in 1998, and the amount of diesel fuel con-
sumed also increased in parallel (15). Over
the same period, the total motor vehicle fuel
consumption nearly tripled (58 to 155 billion
gallons/year) (15). Traffic density has also
increased in many cities along with stagnation
in fuel economy since the early 1980s (15).
As a result, it is expected that concentrations
of trafﬁc-related pollutants will have increased
in certain urban microenvironments. It is rel-
evant that minority groups most at risk for
poor asthma management and subsequent
disease progression are more likely to live in
areas failing to meet the NAAQS. This
includes 80% of Hispanics and 65% of
Blacks compared with 57% of Whites in the
United States (16).
Asthma has been deﬁned as having three
phenotypic characteristics: intermittent and
reversible airway obstruction; increased airway
responsiveness to contractile stimuli; and air-
way inﬂammation. Pulmonary inﬂammation
is a hallmark of asthma and is directly related
to asthma severity as a function of acute and
chronic airflow obstruction. One potential
mechanism of action for air toxics is through
enhancement of airway inflammation.
Inﬂammation in asthma, however, has diverse
pathways, mirroring the complexity of the
disease. Three general mechanisms of inﬂam-
mation in asthma include immunoglobulin E
(IgE)-mediated, neurogenic, and irritant
induced. 
The principal inﬂammatory mechanism in
asthma is an IgE-mediated reaction whereby
an antigen cross-links with an IgE antibody
speciﬁc to that antigen on the surface of mast
cells and other immune cells. Commonly rec-
ognized antigens that induce acute exacerba-
tions of asthma are high molecular weight
allergens such as pollen, fungal and animal
proteins. Low molecular weight agents
involved in IgE-mediated reactions, including
certain air toxics, act as haptens. Haptens must
ﬁrst react with endogenous or exogenous pro-
teins to form a complete antigen (e.g.,
formaldehyde-albumin). IgE-mediated mecha-
nisms are key in early-phase asthmatic reac-
tions (within minutes). Other processes follow
over several hours and involve the recruitment
of eosinophils, CD4+T cells, neutrophils,
basophils, and macrophages, and the release of
proinflammatory mediators and cytokines.
T-cell activation leads to the release of T-
helper cell type 2 (TH2)-like cytokines, which
may be involved in a more prolonged chronic
phase of inﬂammatory response over days (14).
The involvement of TH2 cells is important
because a key pathway to the development of
the asthma phenotype is believed to be the
early differentiation of T-helper lymphocytes
into TH2 rather than TH1 cells, although this
is still controversial (17). TH1 cells participate
in delayed-type hypersensitivity reactions. TH2
cells promote antibody immune responses, and
because they secrete eosinophil-active
cytokines and enhance IgE synthesis, they are
implicated in the genesis of allergic inﬂamma-
tion. Putative progenitor T cells develop into
early TH0 cells with the first antigen
encounter. TH0 cells then differentiate into
TH1- or TH2-type lymphocytes after repetitive
antigen stimulation (18). Interleukin (IL)-4
shifts the differentiation from TH1 to TH2.
The balance toward TH2 cells may be tipped
by early environmental inﬂuences, including
exposure to air pollutants (19), coupled with
genetic susceptibilities. This is presumed to be
key in the development of asthma. 
Neurogenic inflammation involves a
spread of the inflammatory response via the
release of neurotransmitters or activation of
afferent nerves by the action of inﬂammatory
mediators (20,21). Inflammatory mediators
can trigger the activation of nonadrenergic,
noncholinergic nerves to release tachykinins.
A cascade of bronchoconstrictive reﬂexes and
of inﬂammatory events can follow. 
Reactive airways dysfunction syndrome
(RADS) is a primary example of a type of
asthma where toxic irritant-induced
inﬂammation is a key mechanism. RADS has
been identiﬁed in occupational settings and is
defined as an irritant-induced nonimmuno-
logic asthma with no latency period. RADS is
nonimmunologic in the sense that bronchial
epithelial injury is the primary causal event
and typical phases of the immune response
are absent, namely, sensitization, latent
period, episode of elicitation of an immune
response to antigen, and repetitive elicitation
(22). RADS is an example of an inflamma-
tory mechanism of air toxics, but it is rare
and its relevance to nonoccupational asthma
is unclear. 
There is hypothesized to be a feedback
loop between inflammatory processes and
neuronal processes that trigger inﬂammation
(Figure 1) (3). The inflammatory processes
can be either immune mediated (e.g., IgE
mediated) or triggered by irritant-induced
airway injury. For RADS (22), and to some
extent oxidant pollutants such as O3 (23),
the initiation of bronchial epithelial injury
could initiate the release of inflammatory
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Immune-mediated triggers: e.g., allergens, viruses, haptens
Irritant triggers: epithelial injury from irritant pollutants (e.g.,
oxidants, agents involved in reactive airways dysfunction syndrome)
Inflammation: vasodilation, leukocyte recruitment
and activation, mediator production, mucus secretion,
ciliary movement
Neuronal activation
Neuronal triggers: e.g., chemical irritants, (O3, cigarette
smoke, air toxics—toluene diisocyanate, VOCs), osmolarity
changes, mechanical irritants, emotion
Neuopeptides: tachykinins (substance P,
neurokinins A and B), etc.
Smooth-muscle
contraction
Figure 1. Hypothetical feedback loop between inflammatory processes and neuronal processes that
trigger inﬂammation. Adapted from American Thoracic Society Workshop (3).mediators. This inflammation could then
trigger neurogenic inflammation. Chemical
irritants may also act as neuronal triggers
directly (3,24). Irritant-induced induction of
tachykinin release could serve to enhance
ongoing inﬂammation in the asthmatic lung
caused by known immune triggers. Examples
consistent with this hypothetical mechanism
include the putative interaction between
ozone and pollen in asthma exacerbations
(25), and the finding in subjects with mild
asthma that airway responsiveness to inhaled
allergen increases after ozone challenge (26).
Airborne irritants could also indirectly
enhance neuroinﬂammation by inhibition of
neutral endopeptidase (NEP). NEP degrades
tachykinins and its levels are decreased fol-
lowing exposure to oxidants (27), cigarette
smoke (28), and an agent responsible for a
form of occupational asthma, toluene
diisocyanate (TDI) (29). 
In addition to inﬂammatory mechanisms,
the heterogeneity of asthma is further
evidenced by other factors, including 
• differences in etiology and clinical outcomes
between pediatric and adult asthma, which
are poorly delineated to date (30,31);
• variability in the importance of atopy, with
both allergic and nonallergic types being
described, although both show similar pro-
files of inflammatory mediators with the
possible exception of IL-4 (14); 
• specific inducers of acute asthma, includ-
ing allergenic, largely high molecular
weight agents (e.g., fungal spores, animal
proteins), and nonallergenic, largely low
molecular weight agents that may act as
irritants (e.g., O3) or as haptens (e.g.,
formaldehyde) (32); and
• severity and response to treatment.
Given the diversity of both causal deter-
minants and clinical characteristics of asthma,
it is a great challenge to understand its etiol-
ogy. Therefore, it should not be surprising
that the role that air toxics play in asthma
onset and exacerbation is poorly understood. 
Occupational Asthma
A recent review of the literature suggests that
the proportion of new or exacerbated asthma
in adults due to workplace exposures ranges
between 5 and 25% (33). The basic mecha-
nisms deﬁning new-onset occupational asthma
include a) IgE-mediated, which occurs after a
latency period and is caused by high molecular
weight (>5 kDa) allergens, or low molecular
weight compounds (e.g., acid anhydrides, met-
als) that act as haptens; b) unknown immuno-
logical, which occurs after a latency period, but
no IgE- or non–IgE-mediated mechanism is
known (e.g., polyisocyanates such as TDI);
and c) nonimmunologic, namely, the mecha-
nism for RADS, which occurs after single or
multiple exposures to high concentrations of
nonspecific irritants (e.g., hydrogen sulfide
[H2S], chlorine gas, fire smoke) leading to
bronchial epithelial injury and neurogenic
inﬂammation (22).
Occupational data have the potential to
guide research into asthma and community
air toxics exposures. Some of these data are
reviewed below. However, there are limita-
tions in using occupational data on air toxics
to better understand community exposure–
response relationships, as follows: 
• Concentrations of airborne chemicals are
often high in occupational settings, particu-
larly for RADS, whereas in community set-
tings lower exposures are expected (e.g.,
ambient H2S from pulp mill emissions vs.
occupational H2S exposures linked to
asthma). 
• Typically, single-causal agents are identiﬁed
in occupational asthma, whereas complex
mixtures are encountered in ambient air,
making it more difﬁcult to ascribe causality
to any one agent in ambient air. 
• Dose–response relationships are often not
well enough established in the occupational
data to allow an extrapolation to low levels
of prolonged ambient exposure. 
• There may be no similar exposures in ambi-
ent air except for occasional fugitive emis-
sions from industrial sites that could impact
asthma and allergic sensitization locally
(e.g., TDI) (34). 
• The importance of allergenic cofactors to
effects from air toxics may be less important
in occupational asthma compared with
nonoccupational asthma, where common
allergens may be the predominant and most
frequently encountered causal determinant
of asthma ﬂares. 
• Occupational asthma affects adults, whereas
the majority of asthma in the community is
pediatric, and there are clinical and proba-
bly etiological differences, depending on age
of onset (31). 
• Even limiting comparisons to adults, there is
still the problem of the healthy worker
effect in occupational studies. This is a form
of confounding bias where persons of good
health are selected for employment and/or
they choose to be selected. Additionally,
early in employment, workers will choose to
quit when ill, or when work conditions are
perceived to cause illnesses such as asthma.
This limits the applicability of findings to
the general adult population, particularly
for negative results. 
Despite the above limitations, several
agents known to cause occupational asthma
should be investigated in relation to nonoccu-
pational asthma. Categories of low molecular
weight agents associated with occupational
asthma are shown in Table 1 (22). One of the
aldehydes, formaldehyde, is a compound for
which there is epidemiologic evidence for res-
piratory allergic responses in children
(reviewed below). However, many major low
molecular weight agents commonly present in
ambient air have not been clearly identiﬁed as
causes of occupational asthma despite poten-
tially high workplace exposures. These include
polycyclic aromatic hydrocarbons (PAHs)
such as benzo[a]pyrene, some petroleum-
related volatile organic compounds (VOCs)
such as benzene, toluene, and xylenes, and
some industrial process-related VOCs such as
carbon tetrachloride, chloroform, 1,4-
dichlorobenzene, and trichloroethane.
PAH Exposures 
PAHs are found in relatively high concentra-
tions in automobile and DE, along with other
potentially important chemicals including
nitroaromatics, aldehydes, alcohols, ketones,
quinones, phenols, and other organic com-
pounds, as well as volatile co-pollutants—
oxides of nitrogen and of sulfur, CO, and
numerous VOCs such as formaldehyde, ben-
zene, and 1,3-butadiene. Diesel exhaust parti-
cles (DEPs) have a submicrometer elemental
carbon core coated with organic compounds
(including PAHs), nitrites, sulﬁtes, and trace
metals. The most common type of PAH
compound in DEPs includes the phenan-
threnes, followed by fluorenes, fluoran-
threnes, naphthalenes, and pyrenes (35).
However, PAHs are semivolatile, and so
much of the PAHs emitted from motor vehi-
cles is not particle bound. Selected indoor
home concentrations of various semivolatile
PAH compounds for 33 homes in California
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Table 1. Low molecular weight agents associated with occupational asthma.a
Chemical category Examples
Diisocyanates TDI
Acid anhydrides Phthalic anhydride
Aliphatic amines Ethylene diamine
Ethanolamines Monoethanolamine
Heterocyclic and other aromatic amines Piperazine hydrochloride
Metals Halogenated platinum salts, chromium, cobalt, nickel, zinc
Aldehydes Formaldehyde
Drugs Penicillins, cephalosporins
Reactive dyes Carmine
Biocides Chloramine T
Miscellaneous chemicals Styrene, polyvinyl chloride fumes, aziridine 
aData summarized from Bernstein et al. (22).and Ohio ranged from 9.2 to 210 ng/m3 for
phenanthrene, 0.29 to 1100 ng/m3 for
quinoline, 2.40 to 37.4 ng/m3 for fluoran-
threne, and 0.00 to 4.13 ng/m3 for
benzo[a]pyrene (36). Concentrations were
higher in homes with tobacco smoking.
Phenanthrene, for example, was 87 ng/m3 for
homes with smoking and gas stove/heat ver-
sus 31 ng/m3 for nonsmoking homes with gas
stove/heat. PAH concentrations are also likely
to be higher where there is a high density of
trucks, such as downtown Los Angeles,
California, where DE was found to make up
32.7% of the ﬁne particle mass (37). 
The following section will examine some
of the experimental evidence for the potential
causal role of PAHs in asthma, as well as
complementary epidemiologic evidence from
both the occupational and non-occupational
literature. 
Overview of Experimental
Evidence for PAHs as
Proinﬂammatory Compounds
The experimental evidence that suggests an
important mechanistic role for PAHs from
DEPs in allergic respiratory illnesses has been
extensively reviewed before (38), so the pre-
sent section serves as a brief overview.
Takenaka et al. (39) showed that IgE produc-
tion in puriﬁed B cells following the addition
of IL-4 and CD40 monoclonal antibody was
enhanced 20–360% by the addition of an
extract of PAH from DEPs. The effect was
replicated with 2,3,7,8-tetrachlorodibenzo-p-
dioxin, demonstrating that the action of the
PAH extract was likely attributable to aro-
matic hydrocarbons rather than a DEP conta-
minant, possibly acting through aryl
hydrocarbon receptor–mediated effects on
nuclear activities. Tsien et al. (40) also found
in vitro enhancement of IgE production in
human B cells using a total PAH extract of
DEPs, as well as the major PAH component
of DEPs, phenanthrene. 
Diaz-Sanchez et al. (41) found that topi-
cal treatment of nasal epithelium with the
corticosteroid drug ﬂuticasone inhibited sig-
niﬁcant increases in cytokine messenger RNA
(mRNA) for IL-4 and IL-5 after ragweed
challenge, but it did not block a greater
cytokine mRNA production after DEP chal-
lenge. The authors suggested that ﬂuticasone
was unable to inhibit a broad polyclonal acti-
vation because of an adjuvantlike activity of
DEPs. They cited earlier evidence that
intranasal challenges with DEPs leads to sig-
nificant increases in many cytokines (42),
whereas allergens such as ragweed predomi-
nantly increase IL-5 (43). In addition, the
increase in allergen-speciﬁc IgE with ragweed
alone is less than a combined challenge with
ragweed plus DEPs (43,44). Interestingly,
Fujieda et al. (44) found that DEPs plus
ragweed exposure also drives in vivo isotype
switching to IgE in nasal lavage cells from
humans with ragweed allergy but not either
exposure alone.
PAHs from DEPs enhance IgE responses,
but does DEP exposure induce initial atopic
sensitization? Diaz-Sanchez et al. (45) tested
this using a neoallergen (keyhole limpet
hemocyanin [KLH]) to which subjects could
not have been previously exposed. When 10
atopic human volunteers were nasally immu-
nized with KLH, anti-KLH immunoglobulin
G and immunoglobulin A were produced
after KLH challenge but not IgE. In 15 other
subjects, the KLH immunization was pre-
ceded by DEP administration 24 hr previ-
ously. KLH challenge in 9 of these subjects
led to the additional production of anti-
KLH–speciﬁc IgE. 
Clinical relevance of the nasal challenge
studies to lower respiratory allergic
responses remains to be established. Salvi et
al. (46) exposed 15 healthy subjects to clean
air and DE on different days over 3 weeks
and examined lung function, airway lavage,
and bronchial biopsies 6 hr after 1-hr expo-
sures (PM10, 300 µg/m3; NO2, 1,600 ppb;
formaldehyde, 260 µg/m3). They saw
increases in neutrophils and B lymphocytes
in lavage fluids. Bronchial biopsies showed
increased inflammatory cells (neutrophils,
mast cells, CD4+, and CD8+ T lympho-
cytes) and significant increases in expression
of endothelial adhesion molecules and their
ligands. Increases in neutrophils and
platelets were found in peripheral blood.
There were no significant changes in lung
function, but the effect on the asthmatic
lung remains to be tested. 
In summary, PAHs from fossil fuel
combustion may contribute to worsening res-
piratory allergic responses and induction of
the initial clinical expression (38). Potential
targets for PAHs include antigen-presenting
cells, macrophages, mast cells, respiratory
epithelial cells, and possibly TH2 cells directly.
All of these cells are thought to possibly play a
role in the adjuvant effects of DEPs on allergic
inflammation (38). Experimental findings
have shown that whereas DEPs alone have a
nonspeciﬁc effect in increasing cytokine pro-
duction, DEPs plus ragweed antigen selects
against a TH1 proﬁle while stimulating a TH2-
type response (38). The clinical relevance of
these experimental findings remains to be
established, especially for asthma. The rele-
vance to public health and to epidemiologic
findings of air pollution health effects also
remains to be established. The ability of PAHs
to exacerbate disease severity among asthmatic
individuals has not been directly investigated
in an epidemiologic study. The following
review of the epidemiologic literature involves
complex exposure mixtures that contain
relatively high concentrations of PAHs along
with other potentially causal pollutants.
Occupational Evidence for
Respiratory Effects of DE
Occupational exposures to DEP can be high,
thus giving researchers the opportunity to
examine associated health effects. Exposures
range from 1 to 100 µg/m3 for 8-hr averages
in occupations such as trucking or transporta-
tion where mixed automobile and truck expo-
sures are expected. Exposures are much
higher for other occupations such as under-
ground mining, which uses diesel equipment
operated in enclosed spaces, and range from
100 to 1,700 µg/m3 (47). 
A case report of three railroad workers is
the only paper linking new-onset asthma to
occupational DE exposures (48). The workers
developed asthma after exposure to locomo-
tive exhaust while riding immediately behind
a lead engine. However, all had been working
for the railroad for many years, which leaves
open a role for chronic exposures. They had
no previous history of asthma or other
chronic lower respiratory disease and were
nonsmokers. One subject had a history of
seasonal rhinitis, and one had a family history
of asthma and rhinitis, suggesting underlying
susceptibility. The diagnosis was confirmed
by spirometry, airways hyperreactivity to
methacholine, and exercise challenge. Two
workers showed reversibility in lung function
deficits with an inhaled bronchodilator; the
other showed reversibility 3 years later. All
three experienced asthma symptoms upon
reexposure to locomotive DE, and one
showed peak expiratory flow (PEF) rate fall
with work exposure. All developed persistent
asthma with exacerbations occurring with
various triggers including exertion, cold air,
and passive smoke. One other paper reported
a similar high-exposure event involving 13
railroad workers, two of whom complained of
chest tightness and wheezing, but no other
diagnostic data were provided (49). In addi-
tion to the above case report, a number of
cross-sectional occupational studies of DE-
exposed workers have been conducted. 
An early study of 200 coal miners found
no association between diesel exposure and
respiratory health (50). A better-designed
study by Reger et al. (51) showed adverse
effects in 823 miners in diesel coal mines fre-
quency-matched to 823 miners in nondiesel
coal mines by age, height, smoking status,
and years underground. Persistent cough and
phlegm were significantly higher in diesel-
exposed workers, but the opposite was found
for dyspnea; there was no difference in
wheezing. Compared with nondiesel workers,
diesel workers also had signiﬁcant decrements
in FVC, FEV1, and forced expiratory flow
rate at 75% and 90% of FVC (FEF75 and
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the ratio FEV1/FVC. Other studies were con-
ducted by some of the same investigators in
coal mines. One study of acute effects of DE
during an 8-hr work shift in 90 coal miners
compared diesel-exposed and unexposed min-
ers (52). Investigators found that cross-shift
deﬁcits in FEV1, FVC, and forced expiratory
flow rate at 50% of FVC (FEF50) were
greater for diesel-exposed subjects, but not
significant. The same group conducted a
5-year prospective study of 280 diesel-
exposed and 838 unexposed miners in differ-
ent mines (53). They found no significant
age-adjusted differences in 5-year changes in
FEV1 or FVC, or in chronic cough, phlegm,
or breathlessness. However, diesel-exposed
western miners who, unlike the eastern min-
ers, provided the control group, showed a sig-
niﬁcant deﬁcit in FEF50. An internal analysis
of diesel-exposed workers based on cumula-
tive years of diesel exposure was negative. 
A study by Gamble et al. (54) of 283
diesel bus garage workers compared with
blue-collar controls, showed garage workers
had a signiﬁcantly higher incidence of cough,
phlegm, and wheezing adjusted for age, race,
and smoking. However, pulmonary function
was, on average, higher in garage workers
than the controls by all race and smoking sta-
tus categories adjusted for age and height. An
internal comparison based on tenure showed
progressively decreasing FEV1, FVC, and
FEF50 adjusted for age, height, race, and
smoking status. The internal comparison also
showed a consistent increase in prevalence of
dyspnea, wheeze, and cough with tenure. The
same research group studied 259 salt miners
in five mines with different diesel exposures
(2 with extensive diesel use, 2 with limited
use, 1 with none) (55). There was a non-
signiﬁcant increased trend in cough and dysp-
nea and a signiﬁcant trend in phlegm by years
of tenure in diesel-exposed jobs but no associ-
ation with lung function adjusted for smok-
ing, age, and height. The adjusted prevalence
of cough and phlegm was also higher than
that of a blue-collar comparison group, but
lung function did not differ.
None of the above papers compared
groups based on any actual pollutant
measurements. However, the same 259 salt
miners discussed above were studied with
personal samples of NO2 and respirable parti-
cles (cyclone sampler). The personal samples
were used to estimate cumulative exposure by
tenure, with NO2 as a surrogate measure of
diesel exposure (56). Cough, dyspnea, and
pulmonary function (FVC, FEV1, peak ﬂow,
FEF50, FEF75) were not associated with esti-
mated cumulative NO2 (mean 200–2,500
ppb) or respirable particle exposure (mean
200–700 µg/m3). Only phlegm was associ-
ated with the exposures. Gamble et al. (57)
also used personal samples of NO2 and
respirable particles to assess acute effects in
232 of the 283 diesel bus garage workers in
their previous paper discussed above. Both
NO2 (mean 230 ppb) and respirable particles
(mean 240 µg/m3) exposures were associated
with increased postwork shift symptoms of
cough, difficult or labored breathing, chest
tightness, and wheeze but not lung function.
Attﬁeld et al. (58) studied 630 miners in six
potash mines in New Mexico with different
exposures and exposure durations to under-
ground DE. They also used personal passive
samples of NO2 (range 100–3,300 ppb).
Internal analysis showed average percent pre-
dicted FEV1 and FVC were not associated
with particular mines in nonsmokers or
smokers (adjusted for pack years). Lung func-
tion and symptoms were not associated with
predicted cumulative NO2 exposure.
However, when years of exposure were exam-
ined, lung function actually improved and
there was no trend in symptoms (cough,
phlegm, dyspnea), suggesting a harvesting
effect that selected against workers with
adverse pulmonary responses. Robertson et al.
(59) studied 44 matched pairs of coal miners
differently exposed to NO2 and found no dif-
ference in respiratory symptoms or FEV1.
Purdham et al. (60) found that work shift
changes in FEV1 among 17 stevedores
employed in ferry operations did not differ
from those of 11 office controls. Area mea-
surements of NO2, formaldehyde, and
acetaldehyde were also not different, but poor
precision was possible.
Other occupational studies have exam-
ined workers exposed to automobile exhaust,
which can include diesel fumes as well.
Studies by Speizer and Ferris (61,62) com-
pared two groups of policemen with different
exposure levels to auto exhaust and found no
significant differences in symptoms or pul-
monary function. Ayres et al. (63) showed
tunnel workers had worse pulmonary func-
tion and more respiratory symptoms than
bridge workers with lower exposures.
Ulvestad et al. (64) compared 221 tunnel
workers with 205 heavy-construction work-
ers. They found tunnel workers, but not
heavy-construction workers, had significant
decreases in percent predicted FVC and FEV1
with tenure, adjusted for smoking and atopy
by radioimmunoassay test (RAST). Tunnel
workers reported significantly more respira-
tory symptoms than referent workers, and
prevalence of chronic obstructive pulmonary
disease was also higher. However, in an earlier
study there were no differences in the preva-
lence of respiratory symptoms between tunnel
and turnpike workers, although both may
have been highly exposed (65). A small study
of 89 workers on roll-on roll-off ships, car fer-
ries, and a bus garage showed significant
FEV1 and FVC decrements during workdays
after several days with no exposure (66). 
The above occupational studies, most of
which are cross-sectional in design, reveal a
mixed picture of adverse and null effects.
Other pollutant exposures such as coal dust
could have been responsible for positive asso-
ciations in internal comparisons, as well as for
positive and negative findings in between-
group comparisons because both groups were
usually in occupational groups exposed to air-
borne pollutants. Control for adverse smok-
ing effects, which were generally strong, may
also have been inadequate or subject to unde-
tected multicollinearity or interaction.
However, it is likely that the healthy worker
effect strongly inﬂuenced ﬁndings. Therefore,
the limited findings of adverse effects in
working men supports the expectation of
stronger associations in susceptible individu-
als in the general population, including peo-
ple with current asthma, children, and the
elderly. Evidence for a healthy worker effect is
that in many of the studies, workers had
higher baseline FEV1 values compared with
those of control groups or with advancing
tenure (50,51,53,54,58,60). There is other
evidence in the occupational literature on
diagnosed occupational asthma in bakers, and
on allergic sensitization to platinum salts and
to TDI, that risk is greatest in the initial 1- to
2-year period of employment (67). Except for
the case report of “diesel asthma” (48), none
of the occupational studies reviewed above
performed standard spirometric tests to diag-
nose asthma, and none followed workers
prospectively from the start of employment.
Epidemiologic Evidence for
Pollutant Mixtures Containing
PAHs: Environmental Tobacco
Smoke
One common indoor air pollutant high in
PAHs is environmental tobacco smoke
(ETS). ETS also contains other toxic air pol-
lutants, including 29 air toxics of 49 major
components (68), making it difficult to
ascribe effects to any one pollutant. Serum
IgE is higher in smokers than in nonsmokers
(69–72) and is possibly higher in ETS-
exposed subjects (72,73). This suggests an
acute enhancement of IgE responses is possi-
ble, but whether the initial expression of aller-
gic sensitization is enhanced by ETS is in
dispute. A quantitative meta-analysis of stud-
ies up to April 1997 showed no association
between parental smoking during pregnancy
or infancy and atopic sensitization by skin
prick tests (SPTs) in children without asthma
or wheezing disorders (73). There was consid-
erable inconsistency across studies (73).
Other more-recent reviews have concluded
that the relationship between ETS exposure
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of both asthma and allergy is poorly under-
stood (74,75). A recent study of 5,762
school-age children had sufficient power to
ﬁnd a signiﬁcant association between in utero
exposure to maternal smoking without subse-
quent ETS exposure and history of physician-
diagnosed asthma, current asthma, and
asthma requiring medication (76). The same
study showed that although current or past
ETS exposure occurring only after birth was
associated with reports of wheezing, it was
not associated with asthma prevalence.
Furthermore, combined in utero plus postna-
tal exposures did not increase risk of asthma
beyond in utero exposures alone. The ﬁnding
that maternal smoking during pregnancy has
a stronger relationship to asthma onset than
later ETS exposures was supported by several
other studies that separated maternal in utero
exposures from postnatal exposures (77–82).
It is conceivable that in utero exposures to
ETS shifts the immune response toward a
TH2-type pattern as a result of the adjuvant
action of PAH components interacting with
in utero allergen exposures, which are now
believed to lead to atopic sensitization before
birth (83,84). It is plausible that postnatal
coexposures would do the same, but the
epidemiologic data are inconsistent for the
relationship between ETS exposure and
childhood asthma incidence. 
On the other hand, there is a preponder-
ance of evidence linking ETS to acute exacer-
bations of asthma in asthmatic children. A
recent meta-analysis concluded that studies
showed an excess incidence of wheezing in
smoking households, particularly in
nonatopic children, suggesting a “wheezy
bronchitis” pattern; however, in children with
diagnosed asthma, parental smoking was
associated with greater severity rather than
incidence (78). A quantitative meta-analysis
of studies up to April 1997 for 25 studies of
asthma prevalence showed a pooled odds
ratio (OR) for asthma of 1.21 (95% confi-
dence interval [CI], 1.10–1.34) if either par-
ent smoked (85). Well-conducted panel
studies are still needed to evaluate acute
exposure–response relationships using
repeated measures methods. A recent daily
panel study over 3 months in 74 asthmatic
children showed that acute asthma symptom
severity, PEF, and bronchodilator use was
associated with ETS exposure (86).
There is less information about adult-
onset asthma. A cohort study of 451 non-
smoking asthmatic adults found that acute
asthma severity, asthma-specific quality of
life, and health status were associated with
self-reported ETS exposure (87). Cohort
studies have also shown increased risk of
developing adult asthma from ETS (88),
including occupational exposures (89).
Among 3,914 nonsmoking adults followed
10 years, the relative risk for asthma onset
from 10 years of working with a smoker was
1.45 (95% CI 1.21, 1.75) (85). A large sur-
vey of 4,197 never-smoking adults showed an
elevated risk of physician-diagnosed asthma
from any ETS exposure [OR 1.39 (95% CI
1.04–1.86)] but no increased risk of allergic
rhinitis (90). Reviews that have included
other epidemiologic studies have concluded
that although ETS is consistently associated
with adult asthma onset, the number of stud-
ies is limited and the magnitude of effects are
small, with limited dose–response informa-
tion (91,92). One question that remains to be
answered is what are the chemical determi-
nants of associations between asthma and
ETS, which is a complex mixture of particle
and gas-phase components? Do PAHs play a
major role in these associations?
Epidemiologic Evidence for
Pollutant Mixtures Containing
PAHs: Automobile and Truck
Exhaust
The urban exposure most relevant to the
potential importance of PAHs to asthma is
exposure to automobile and truck trafﬁc. An
earlier descriptive study spurred interest in
potential adjuvant effects of DEP on IgE-
mediated respiratory allergic responses (93).
This was a cross-sectional study of 3,133
Japanese persons that showed the prevalence
of cedar pollen allergy was higher near busy
highways despite equivalent local exposure to
cedar pollen in less-busy areas.
No epidemiologic studies have used
quantitative exposure estimates of either DEP
or ambient PAHs. However, European
research has had access to black smoke mea-
surements. A panel study of 61 (77% on
asthma medications) children in the summer
showed stronger associations for black smoke
than for PM10 in relation to PEF, respiratory
symptoms, and bronchodilator use (94). The
authors hypothesized that black smoke may
be a better surrogate for ﬁne particles emitted
by diesel engines or for other chemicals that
may be the causal components in DE.
Ambient NO2 could additionally serve as a
marker for traffic exposure. Studnicka et al.
(95) explicitly used outdoor NO2 as a surro-
gate to show “traffic-related pollution” was
associated with asthma prevalence among 843
children living in areas of lower Austria with-
out local industrial emissions of air pollution. 
Numerous epidemiologic studies have
shown associations between traffic density
and asthma prevalence or morbidity. All but
one were conducted in Europe and Asia
(Table 2). Fifteen of these have been in chil-
dren (96–110), four in adults (111–114), and
one study in both children and adults (115).
All but seven have been purely cross-sectional
studies. Krämer et al. (109) conducted a
cross-sectional study of atopic sensitization
and asthma diagnosis but had a prospective
outcome assessment of atopic symptoms for 1
year along with seasonal NO2 measurements.
Other designs include three case–control
studies of hospital admissions (97,99,108),
and one case–control study of California
Medicaid claims for asthma (105). Another
study was a mixture of cross-sectional, survey-
nested case–control, and historical cohort
(110). One study of adult Japanese women
was cross-sectional for symptom prevalence
and also tested longitudinal models for 10
seasonal repeated measures for lung function
in a subsample (112). Eleven looked at trafﬁc
density, but no air pollution measurements
were used in effect estimates or as conﬁrma-
tion of exposure gradients (96–98,100,101,
104,105,108,110,113,114); four had traffic
density, black smoke and/or NO2 (102,103,
111,112); and five used combustion-related
air pollution measurements near the home
(CO, benzene, and/or NO2) as modeled sur-
rogates for traffic exposures (99,106,107,
109,115). Hirsch et al. (107) briefly men-
tioned results for truck traffic, focusing
instead on predicted home exposures from
one hundred eighty-two 1-km2 grid measure-
ments of CO, benzene, NO2, SO2, and O3.
Pershagen et al. (99) used predicted NO2
from models involving traffic data near the
home and background ambient NO2 data,
with home residence time as a weighting fac-
tor. Oosterlee et al. (115) investigated respira-
tory symptom prevalence and asthma in
relation to busy and quiet streets predicted
with model calculations of NO2 concentra-
tions using the Dutch CAR (Calculation of
Air Pollution from Road trafﬁc) model (117).
Only four studies have separately assessed
exposures from truck versus automobile traf-
fic (102–104,113), two of which examined
the same children in South Holland using
actual 1-year measurements of trafﬁc density
in relation to lung function (102) and symp-
toms (103). Another study in Germany had
only self-reported truck trafﬁc density in rela-
tion to symptoms (98). Except for one study
(113), all of the above studies examining
truck trafﬁc showed increased risks in respira-
tory symptoms including wheeze from higher
truck traffic density near the home
(98,103,104). The Holland studies showed
greater increased risks in respiratory symp-
toms including wheeze (103) and lung func-
tion deficits (102) from higher truck traffic
than from automobile density near the home.
Both Holland studies conﬁrmed the possible
relevance of DE by ﬁnding that black smoke
measurements at the children’s schools were
also associated with increased symptoms
(103) and lung function deficits (102). A
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Table 2. Epidemiologic studies of the relationship between asthma prevalence or morbidity and trafﬁc-related exposures.
Reference Design and location of study.
ciitation Subject ages (yr) and characteristics Exposures Health outcomes Results
Wjst et al. Cross-sectional. Trafﬁc density: trafﬁc on the Lung function: FEV1, FEV1/FVC, Regressions controlled for parental history of asthma, parental 
(96) Munich, Germany. road with the highest trafﬁc PEF, FVC, PEFR, MEF25,MEF50, education, passive smoking in home, number of home 
In school districts with multiple large volume passing through MEF75, and MEF50/FVC. residents, gas or coal for cooking or heating, month of survey, 
roadways; 7,000–153,000 vehicles/day. the school district but no Respiratory conditions: and questionnaire respondent (for symptoms). Lung function 
Children: 9–11 yr, living in the same information relating to Respiratory tract infections models also adjusted for test compliance, height, and weight. 
residence 5 years (n = 4,320 pulmonary distance from home or school. (>10 in past year); common Percent difference in lung function per 25,000 cars was 
function; 4,678 questionnaires). cold (symptoms present at signiﬁcant or borderline signiﬁcant (p < 0.1) but small 
exam); coughing, and recurrent (<1%) for FEV1, PEFR, MEF25, MEF50,MEF50/FVC. No 
conditions (bronchitis, association with MEF75 and FVC (p > 0.4).
wheezing, or dyspnea) Respiratory tract infections and recurrent bronchitis were not 
Physician-diagnosed illness: signiﬁcantly associated with trafﬁc. Small signiﬁcant 
asthma, croup, allergic rhinitis associations were found for recurrent wheezing 
(self-reported). [OR/25,000 cars 1.08 (95% CI 1.01, 1.16)] and recurrent 
dyspnea [OR 1.10 (95% CI 1.00, 1.20)], borderline associations 
were found for cough [OR 1.06 (95% CI 0.99, 1.13)]. 
Signiﬁcant association for common cold at exam 
suggests possible confounding of lung function. 
Signiﬁcant small OR/25,000 cars were found for lifetime
croup [OR 1.09 (95% CI 1.00, 1.18)], but asthma and allergic 
rhinitis were not signiﬁcantly associated with trafﬁc.
Edwards Case–control. Trafﬁc density: major roadway Cases admitted to hospital Only unadjusted results were given. Cases lived more often 
et al. (97) Birmingham, West Midlands, UK. on or near home. with asthma. near roads with high trafﬁc density than community 
Homes near many busy roads with  Binary classiﬁcation: controls [OR 1.40 (95% CI 1.13, 1.74)] and hospital controls 
trafﬁc congestion. <24,000 versus >24,000/day [OR 1.29 (95% CI 1.04, 1.50)]. Ordinal trafﬁc density showed a 
Children: cases 0–4 yr admitted to Ordinal classiﬁcation: signiﬁcant trend for subjects living < 500 m from a major 
hospital for asthma (n = 715), versus > 35,000; 28,000–35,000;  road (p-value for trend <0.006).
community controls (n = 736), and versus 24,000–27,000; 20,000–23,000;  Cases were more likely to live 0–200 versus >200 m than 
nonrespiratory hospital controls (n = 722). 14,000–19,000; <14,000/day. community controls [OR 1.52 (95% CI 1.22, 1.90)], but not 
Distance to roadway home within  hospital controls [OR 1.16 (95% CI 0.94, 1.44)].
0–200 m; 201–500 m; >500 m.
Weiland Cross-sectional. Truck trafﬁc density: subject Respiratory symptoms (recalled Logistic regressions controlled for age, gender, nationality,
et al. (98) Bocham, Germany. self-reported frequency of truck for last year): parental history of asthma, parental education, passive
Children: 12–15 yr (n = 2,050) from 13 trafﬁc (never, seldom, frequent, Wheezing—written and video smoking in home, active smoking, number of siblings, single 
randomly selected schools. and constant). questionnaires (ISAAC). bedroom, pets, and bedroom carpets.
Allergic rhinitis symptoms— Increased prevalence of wheezing by video questionnaire for
written questionnaires. more truck trafﬁc: frequent versus never [OR 1.58 (95% CI 1.13, 
2.20)], constant versus never [OR 1.94 (95% CI 1.26, 2.99)],
consistent with ORs using written questionnaire.
Increased prevalence of allergic rhinitis for frequent versus
never [OR 1.67 (95% CI 1.17, 2.38)], constant versus never
[OR 1.54 (95% CI 0.97, 2.44)].
Pershagen Case–control. Ambient air pollution: NO2 (µg/m3:  Cases diagnosed with wheezing Logistic regressions controlled for parental asthma and 
et al. (99) Stockholm, Sweden. <35, 35–45, 46–70, >70)  bronchitis (from administrative maternal smoking.Cases had higher predicted NO2 exposures 
St. Goran’s Children Hospital. predicted from dispersion models  data). than controls, restricted to girls only: Ordinal p for trend 
Children: 4–48 months (n = 197) admitted to  involving trafﬁc data near the  <0.02; OR for >70 versus <35 µg/m3 NO2: 2.7 (95% CI 1.1, 6.8).
hospital for breathing difﬁculties with home and day care center, back-
wheezing versus 350 controls 4–48 months ground ambient NO2, and time in
of age recruited from hospital catchment  months at home and day care
area; frequency matched for age. addresses.
Waldron Cross-sectional. Trafﬁc density:  Respiratory symptoms: Unadjusted comparisons only with chi-square tests showed
et al. (100) East Surrey, Great Britain. Binary classiﬁcation of wards: Ever wheezing; in past year: no associations in relation to wards having versus not having
Rural and urban wards with and motorway versus nonmotorway. wheezing, sleep disturbance a motorway. 
without motorways. There was no deﬁnition of from wheeze, speech limitation
Children: 13–14 yr (n = 2,324). motorway, and a ward was from wheeze, wheeze after
classiﬁed as motorway if any exercise, dry cough at night,
part of the motorway passed and ≥4 wheezing attacks.
through it. Physician-diagnosed asthma
(self-reported).
Duhme Cross-sectional. Trafﬁc density: self-reported Respiratory symptoms (recalled Logistic regressions controlled for age, gender, parental history 
et al. (101) Münster, NW Germany. frequency of truck trafﬁc near for last year):  of asthma, passive smoking at home, and active smoking. 
Administrative city with few industrial home (never, seldom, frequent, Wheezing—written and Found increased prevalence of wheezing by video questionnaire 
areas; urban and rural settings sampled and constant). video questionnaires (ISAAC). for more truck trafﬁc: frequent versus never [OR 1.35 (95% CI 
with various trafﬁc densities. Trafﬁc noise: self-reported Allergic rhinitis symptoms— 1.04, 1.77)], constant versus never [OR 1.94 (95% CI 1.33, 2.84)]. 
Children: 12–15 yr (n = 3,703). frequency of intense trafﬁc written questionnaires. Effects using written questionnaire responses were 
noise near home (never, seldom, consistent. Consistent signiﬁcant trends with ordinal intense 
frequent, and constant). trafﬁc noise.
Found increased age- and gender-adjusted prevalence of 
allergic rhinitis for children; frequent versus never [OR 1.71 
(95% CI 1.36, 2.15)], constant versus never [OR 1.96 (95% CI 
1.40, 2.76)].
Consistent signiﬁcant trends with ordinal intense trafﬁc noise.
Effect modiﬁcation of allergic rhinitis risk seen for duration:
association only found for subpopulation >5 yr in present home
. (Continued)Asthma Occurrence • Delfino
580 VOLUME 110 | SUPPLEMENT 4 | AUGUST 2002 • Environmental Health Perspectives
Table 2. Continued.
Reference Design and location of study.
citation Subject ages (yr) and characteristics Exposures Health outcomes Results
Brunekreef Cross-sectional. Annual (1993) truck trafﬁc density Lung function: Regressions controlled for age, gender, smoking in home, pets, 
et al. (102) Netherlands, Province of South Holland. per region and school. FEV1, PEF, FVC, and FEV25–75%. home dampness or mold, ethnicity, number of home residents, 
Six residential areas with homes near Annual (1993) auto trafﬁc density gas cooking, gas unvented water heaters, and parental 
major freeways; 80,000–152,000  per region and school. education. 
vehicles/day. Distance home to freeway: ≤100 m  Home within 100 m versus >100 m of freeway not signiﬁcant. 
Children: 7–12 yr, lived within 1,000 m  versus >100 m. Deﬁcits found for truck (not auto) trafﬁc density, and deﬁcits 
of freeway assessed in 1995 (n = 778), Indoor school air pollution: NO2,  larger for children living within 300 m of freeway: for 10,000 
[subset of van Vliet et al. (103) below]; black smoke. trucks/day FEV1, –4.1 (95% CI –7.9, 0.1); FVC, –3.6 (95% CI 
85% lived at current residence for 3 or  –7.4, 0.3). 
more years. Pollutant-related deﬁcits larger for children living within 300 m 
of freeway, and signiﬁcant deﬁcits for black smoke: per 
10 µg/m3, FEV1, –3.7 (95% CI –7.7, –0.2); FVC, –2.7 (95% CI 
–6.1, 0.9); FEV25–75%, –6.3 (95% CI –13.2, 1.2). Similar deﬁcits 
for PEF. NO2 signiﬁcant only for FEV25–75% per 10 µg/m3: 
–3.6 (95% CI –7.1, –0.1).
Deﬁcits larger in girls than boys; for 10,000 trucks/day FEV1 for 
boys: –1.8 (95% CI –7.5, 4.2); girls, –8.3 (95% CI –13.0, –3.4).
van Vliet Cross-sectional. Annual (1993) truck trafﬁc  Respiratory symptoms: chronic Logistic regressions controlled for age, gender, smoking in 
et al. (103) Netherlands, Province of South Holland. density per region and school. cough, wheezing, asthma  home, pets, home dampness or mold, ethnicity, number of 
Six residential regions with homes near Annual (1993) auto trafﬁc  attacks, rhinitis. home residents, gas cooking, gas unvented water heaters, 
major freeways: 80,000–152,000 density per region and school. Physician-diagnosed illness: and parental education.
vehicles/day. Distance home to freeway:  asthma, bronchitis  Associations found in girls not boys: 
Children: 7–12 yr, lived within 1,000 m  ≤100 m versus >100 m. (self-reported). For truck (not auto) trafﬁc density (per 9,482 vehicles/day) 
of freeway assessed in 1995 (n = 878). Indoor school air pollution:  Physician diagnosed allergy to and wheeze [OR 3.42 (95% CI 0.98, 11.9)] and asthma 
85% lived at current residence for 3 or NO2, black smoke. pets, dust mites, pollen (self- attacks [OR 4.34 (95% CI 1.12, 16.8)].
more years. reported). Home within 100 m of freeway and chronic cough [OR 2.45; 
95% CI 1.16, 5.16), wheeze [OR 3.05 (95% CI 1.11, 8.41)], 
and rhinitis [OR 2.30 (95% CI 0.96, 5.52)].
Black smoke and chronic cough [OR 2.94 (95% CI 0.98, 8.83)],
and rhinitis [OR 3.06 (95% CI 0.87, 10.8)]. NO2 not signiﬁcant.
Physician-diagnosed asthma was not associated with 
increased exposure, but fewer persons with asthma lived near 
high trafﬁc density freeways. 
Physician-diagnosed allergy was inversely associated with NO2 
and black smoke.
Ciccone Cross-sectional. Trafﬁc density: self-reported Respiratory disease (ﬁrst 2 years Logistic regressions controlled for age, gender, study center, 
et al. (104) Ten sites in northern and central Italy  frequency of trafﬁc near home  of life): bronchitis (>three change of residence, parental history of asthma, parental edu-
with rural and urban settings, including  (absent, low, moderate, and high). episodes), pneumonia,  cation, smoking (self, mother, father, others), number of home
three large cities: Torino, Milan, and Rome. Self-reported number of bus routes bronchiolitis, spastic laryngitis, residents, gas cooking, heating system, month of survey, mater-
Children: 6–7 yr (n = 18,737); 13–14 yr near home (0, 1, and ≥2). wheezing bronchitis (>three nal smoking, bedroom (dampness, mold, bedding), ﬂoor level. 
(n = 21,067).  Self-reported truck transit near episodes), none of the diseases No signiﬁcant associations for overall trafﬁc density.
53.3% of subjects had never moved from home (never or seldom, listed (reference group). Signiﬁcant positive associations found for metropolitan areas 
home since birth. sometimes, and often). Respiratory symptoms (past  for combined respiratory diseases ﬁrst 2 yr of life with bus 
year): wheeze, severe cough,  routes and truck transit: OR for often versus never truck trafﬁc
dyspnea + wheeze, morning  1.39 (95% CI 1.19, 1.62); consistently positive associations 
chest tightness, conditions  across individual respiratory diseases.
apart from colds (nocturnal  Positive associations found for combined respiratory symptoms 
dry coughs, persistent cough,  the last year plus illnesses and bus routes and truck transit:
persistent cough > 2 months, OR for often versus never truck trafﬁc 1.29 (95% CI
persistent phlegm > 2 months),  1.15, 1.45); consistently positive associations across 
none of the conditions listed individual current respiratory conditions.
(reference group). OR for current asthma and truck trafﬁc, often versus never: 1.25
Physician-diagnosed illness: (95% CI 0.99, 1.59), which was higher in children with 
current asthma, asthma attack persistent cough and phlegm for 2 months [OR 1.70 (95% CI
that resulted in hospitalization 1.11, 2.61)]. Asthma hospitalizations (n = 36) were not 
(self-reported). associated with exposure.
English Case–control. Trafﬁc density: average weekday Cases diagnosed with asthma Logistic regressions controlled for race, medical visit type, and
et al. (105) San Diego, Califonia, USA. trafﬁc density within a 550-ft  on Medicaid claims. urban/rural residence.
Children: ≤14 yr; 5,996 cases diagnosed radius around home using GIS on Case-based analysis: cases with Case–control: there were no signiﬁcant associations and all ORs
with ICD-9 code for asthma in the 1993  the street with highest volume, ≥2 versus 1 medical visit per  were close to 1.00 with wide conﬁdence intervals. No differ-
California Medicaid claims database, the closest street, and the sum of year of study. ences were found in separate models by gender or excluding 
including pharmacy visits; 2,284 random all streets weighted using accident controls. 
nonrespiratory control claims. dispersion models without wind Case-based: there were elevated ORs for each quintile of trafﬁc 
data. ﬂow on the nearest street; no evidence of dose-response. OR 
for case having two or more visits versus one with trafﬁc ﬂows 
> 41,000 cars/day (95th percentile): 2.91 (95% CI 1.23, 6.91).
(Continued)Asthma Occurrence • Epidemiologic evidence for asthma and air toxics
Environmental Health Perspectives • VOLUME 110 | SUPPLEMENT 4 | AUGUST 2002 581
Table 2. Continued.
Reference Design and location of study
citation Subject ages (yr) and characteristics Exposures Health outcomes Results
Guo et al. Cross-sectional. Ambient air pollution: annual Physician-diagnosed asthma Two-stage logistic regression. First stage: site-speciﬁc asthma
(106) Taiwan. mean from 55 monitoring sites. (self-reported). prevalences were adjusted for age, history of atopic eczema, 
Children: middle school students attending Principal component analysis Questionnaire-determined and parental education in each of 55 monitoring catchments
schools located within 2 km of 55 air factors:  asthma from student video sites.
pollution monitoring stations  Factor 1: positively associated questionnaire (ISAAC)a report  Second stage: site-speciﬁc asthma prevalences rates were 
(n = 331,686). with CO and NOx, negatively  of dyspnea and nocturnal  adjusted for temperature and relative humidity to assess 
Excluded active smokers. associated with O3 - “trafﬁc  dyspnea associated with  effects of air pollutant factor scores.
related.” wheezing, or parent-reported  Factor 1 was positively associated with physician-diagnosed 
Factor 2: positively associated attacks of dyspnea with  asthma in boys and girls (p < 0.001) and with questionnaire-
with SO2, and PM10 - “industry, wheezing, or parent-reported  determined asthma in boys and girls (p < 0.01). For an inter-
power plants, domestic fuel.” physician-diagnosed asthma. quartile increase in CO (326 ppb) and in NOx (17.3 ppb), the 
Weather: annual mean  prevalence of either physician-diagnosed or questionnaire- 
temperature and RH. based asthma increased around 1% for both boys and girls
Parameters for factor 2 were negative for all models.
Hirsch et al Cross-sectional. Ambient air pollution: SO2, NO2, Respiratory symptoms: Logistic regressions controlled for age group, birth weight, 
(107) Dresden, SE Germany. CO, benzene, O3 measured for  wheezing, morning cough last central heating, maternal smoking, pets, home dampness, 
Children: 5–7 yr (n = 2,796) 9–11 yr 1 yr in 182 1-km2 grids across year. carpets, ﬂoor level, parental education.
(n = 2,625), who lived in Dresden 12 or urban Dresden and geocoded  Atopic symptoms: Wheeze last 12 months was not associated with exposures.
more months. and weighted to the subject’s  Rhinoconjunctivitis, symptoms  Morning cough was positively associated with SO2, NO2, CO, 
Random subsamples of 5- to 7-yr olds and school and home addresses. of atopic eczema. and benzene inversely with O3. Per 1 µg/m3 benzene at home 
all 9- to 11-yr olds were used for SPT  Trafﬁc density: parent-reported Physician-diagnosed illness: plus school OR 1.21 (95% CI 1.04, 1.40). 
(n = 1,138 and 2,050, respectively) and  frequency of truck trafﬁc near Asthma, bronchitis (self- OR from constant truck trafﬁc versus none: for cough, 1.60 
serum IgE (n = 870 and 1,887, respectively). home. reported). (95% CI 1.06, 2.42), for wheeze, 2.09 (95% CI 1.24, 3.53).
Random subsamples of 9- to 11-yr olds were Atopic sensitization: SPT, Tendency for increased prevalence of asthma, but signiﬁcant 
used for lung function (n = 1,137) and BHR  speciﬁc IgE antibodies. only for benzene: OR 1.21 (95% CI 1.01, 1.45). However, in 
(n = 956). Lung function: FEV1, FEF25–75%. subgroup models, effects on asthma prevalence were 
BHR signiﬁcant for nonatopic, children from SO2, NO2, CO, and 
benzene (lower 95% CI ≥ 1.00; ORs 1.29–1.49).
Signiﬁcant increase in prevalence of bronchitis for NO2, CO, 
and benzene (ORs 1.16–1.27).
No association with prevalence of atopic symptoms, atopic 
sensitization lung function, or BHR.
Wilkinson Case–control. Trafﬁc density: modeled vehicle Cases admitted to hospital with Logistic regressions controlled for age, gender, hospital, and 
et al. (108) North Thames (West), UK. meters/hr along roads within asthma (from administrative average census tract SES.
Children: 5–14 yr 1,380 cases with 150 m of the postcode centroid data). For both asthma and all respiratory admissions there was no
Emergency admissions for ICD-9 code of home, linked by GIS. Cases admitted to hospital with signiﬁcant difference for trafﬁc density or distance to nearest 
for asthma; 2,131 cases all ICD-9 Distance: from postcode centroid any respiratory illness (from main road. For asthma, a borderline (p < 0.06) decreasing risk 
respiratory admissions including asthma; of home to nearest main road  administrative data). with increasing trafﬁc was seen.
5,703 controls with nonrespiratory (>150 m versus. ≤ 150 m); and to  No differences were found in separate models by gender.
admissions excluding accident. nearest road with modeled 
peak > 1,000 vehicle-meters/hr.
Krämer Cross-sectional, as well as, prospective  Ambient air pollution. Palmes Respiratory symptoms: Logistic regressions controlled for older siblings, gender, and 
et al. (109) outcome assessment of atopic symptoms  tubes passively sampled NO2 at  wheezing and allergic rhinitis education of parents. Associations were dominated by urban
for 1 yr along with NO2. 158 locations for 1 week in each symptoms reported weekly in subgroup as follows: 
Dusseldorf, W. Germany.  of 4 seasons. Palmes tubes were  diaries over 1 yr. Outdoor NO2, but not personal NO2, was signiﬁcantly 
Two urban areas near major roads and one  used for other NO2 samples in  Physician-diagnosed illness: associated with reports of at least 1 week with symptoms 
suburban area. March and September 1996.  asthma, hay fever, eczema of wheezing [OR for 10-µg/m3 increase: 14.9 (95% CI 2.59, 
Children: 9 yr (n = 306); urban = 204; Analytic variables are interpolated  (self-reported). 86.4)] and with symptoms of allergic rhinitis [OR 1.81 (95%
suburban = 102; lived 2 or more yr at  outdoor NO2 from 158 sites and  Atopic sensitization: SPT  CI 1.02, 3.21)], which in pollen season increased to OR 3.09 
same home. predicted personal NO2 from  (pollen, dust mites/cats, and (95% CI 1.38, 6.92).
actual personal and micro- milk or eggs); serum (IgE  An ever diagnosis of hay fever was associated with outdoor 
environmental NO2. antibodies). NO2 [OR 4.24 (95% CI 1.01, 17.8)]; asthma was not [OR 
1.82 (95% CI 0.36, 9.36)]. 
Atopic sensitization to pollen, house dust mite or cat, and 
milk or egg were each signiﬁcantly associated with outdoor 
NO2 (ORs ranged from 3.5 to 5.0), but not personal NO2. 
(See text and Figure 2.)
Venn et al. Cross-sectional.  Trafﬁc density (24 hr): TAI (meters Respiratory symptoms: past year Prevalence of wheeze adjusted for age and sex in subjects 
(110) Case–control selected within initial survey. traveled/day/km2) for 1 km2 attacks of wheeze and presence 4–11 yr was not associated with continuous TAI, but was 
A cohort subset was taken from historical around subject’s school; no of troublesome cough associated with middle and upper versus lower tertile [OR 1.11 
data on wheeze 7 years previously. information relating to distance (especially at night) apart from (95% CI 1.02, 1.22) and 1.13 (95% CI 1.03, 1.24), respectively].
Nottingham area, United Kingdom. from home. cold or chest infection. Prevalence of cough adjusted for age and sex in subjects 4–11 
Children: TAI tertile (in millions): low ≤ 22; Physician-diagnosed illness: yr was also nonlinearly associated with the middle and upper 
Survey: 4–11 yr (n = 22,986) medium 23–31; high ≥ 32. asthma (self-reported). versus lower tertile TAI [OR 1.21 (95% CI 1.02, 1.44) and 1.22 
11–16 yr (n = 27,826). (95% CI 1.02, 1.45), respectively].
Case–control: 2,648 cases of all children  Prevalence of asthma adjusted for age and sex in subjects 
reporting wheeze, versus random  4–11 yr was also nonlinearly associated with the middle and 
sample of 3,928 controls without  upper versus lower tertile TAI [OR 1.16 (95% CI 1.02, 1.31) 
recent wheeze. and 1.16 (95% CI 1.02, 1.32), respectively].
Cohort: 765 adolescents in both old and  In subjects 11–16 yr there was no association of wheeze, 
new survey. cough, or asthma with either continuous TAI or tertiles.
ORs for wheeze, cough, and asthma in case–control sample 
adjusted for age, sex, social class, and maternal smoking 
were positive but not signiﬁcant.
Weak linear relationship of persistent wheeze in cohort sample 
with TAI (p = 0.06); OR 1.05 (95% CI 1.00, 1.11) per 10 million 
TAI units.
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Table 2. Continued.
Reference Design and location of study.
citation Subject ages (yr) and characteristics Exposures Health outcomes Results
Oosterlee Cross-sectional. Trafﬁc classiﬁcation: binary; busy Respiratory symptoms: chronic Logistic regressions controlled for age, sex, education of 
et al. (115) Haarlem, Netherlands. streets versus quiet streets  cough, cough with phlegm, mother, change of residence, parental history of asthma, 
Children: 106 children (0–15 yr) living predicted with model calculations dyspnea (ever/in past year), passive smoking, presence of an unvented gas hot water 
along busy trafﬁc streets (72% born in of NO2 concentrations based on wheeze (ever/in past year), heater, number of home residents, gas cooking, type of 
same house) compared with 185 control detailed trafﬁc data including dyspnea with wheeze (ever/in heating system, pets, and home humidity.
children living along streets with little trafﬁc density (CAR model) (117); past year). Children: too few with asthma, chronic cough, or cough with 
trafﬁc, same neighborhoods, same estimated trafﬁc density on busy Medication: asthma medication phlegm to analyze. Seven of 9 other ORs ranged from 1.5 to 
housing type (66% born in same house). streets 10,000–30,000  currently; respiratory medication 4.8; only ever respiratory medication was signiﬁcant, and ever 
Adults: 673 adults living along busy vehicles/day. ever.  wheezing was p < 0.06.
trafﬁc streets compared with 812 Physician-diagnosed illness: Effects were dominant in girls and most signiﬁcant: wheeze in 
controls as above. asthma, allergy (self-reported). past year [OR 5.3 (95% CI 1.1, 25.0)], attacks of dyspnea with 
wheeze in past year [OR 15.8 (95% CI 1.4, 174)].
Physician-diagnosed allergy not associated with trafﬁc.
Adults: only dyspnea while walking signiﬁcant: OR 1.8 (95% CI
1.1, 3.0).
Nitta et al. Cross-sectional, three surveys. Distanceto major roadway: Respiratory symptoms: chronic Logistic regressions controlled for age, smoking status, years at
(111) Western suburbs of Tokyo, Japan.  <20 m versus 20–150 m for 1979  wheeze most days or nights residence, education, occupation, and type of home heating.
Three areas with homes near major road- and 1983; <20 m versus 20–50 m,  apart from colds, chronic cough 1979: all ﬁve ORs >1.0, ranging from 1.35 to 2.75, and all but 
ways; 30,000–53,000 vehicles/12-hr day. and versus 50–150 m for 1982. or chronic phlegm 3 or more one symptom (dyspnea) was signiﬁcant.
Adults: Women only, 40 yr of age or older:  Conﬁrmed gradient difference with months last year, dyspnea with 1982: four of ﬁve ORs >1.0, ranging from 1.13 to 1.87; only 
1979 (n = 1,517), 1982 (n = 2,413), and  2–7/day average. NO and NO2. walking, off work with chest (OR 1.87) was signiﬁcant for <20 m versus 20–50 m, and only 
1983 (n = 2,389). Lived 3 or more yr at  illness with phlegm in last 3 yr. chronic cough (OR 1.78) and phlegm (OR 1.85) were signiﬁcant 
same home. for <20 m versus 50–150 m.
1983: Three of ﬁve ORs > 1.0, ranging from 1.26 to 1.66; only 
dyspnea was signiﬁcant (OR 1.66).
Nakai et al. Cross-sectional. Repeated measures for Distance hometo major roadway: Respiratory symptoms: Chronic Logistic regressions controlled for age, smoking status, years at
(112) lung function. Zone A = 0–20 m; B = 20–150 m; wheeze most days or nights  residence, occupation, and type of home heating.
Tokyo, Japan.  C = reference zone in suburbs. apart from colds, chronic cough  Prevalence of chronic cough and chronic phlegm were higher in 
Areas within varying distances from roads Conﬁrmed gradient difference with or chronic phlegm 3 or more  zone A than C [OR 2.18 (95% CI 1.08, 4.42) and OR 1.79 (95% 
with heavy trafﬁc: 30,000–34,000 vehicles/ NO2 (passive indoor, personal,  months last year, dyspnea with CI 1.07, 3.01), respectively]. 
12-hr day (<21% diesel powered), versus  and outdoor at 0, 20, and 150 m  walking. Chronic cough was higher in zone A than B [OR 1.87 (95% CI
referent area away from roads with heavy  from roadside) 2 days each in 10 Lung function: age-and height 1.02, 3.42)]. 
trafﬁc.  seasons, fall 1987 to winter 1990. adjusted FEV1, FVC in subsample Zone B did not differ from C.
Adults: women only, 39–59 yr (n = 1,986). Personal NO2 exposures were  of 200 nonsmoking women There were no consistent differences for wheeze or dyspnea.
Lived 3 or more yr at same home. primarily attributable to trafﬁc  without history of respiratory Longitudinal mixed regression models for lung function decline
if no gas stoves in the home,  disease; repeated measure- showed no consistent differences by zone.
as reported in Nakai et al. (116). ments each of 10 seasons.
Montnémery Cross-sectional. Trafﬁc classiﬁcation: Binary.  Respiratory symptoms: Asthma Symptom prevalence rates were adjusted for age and gender 
et al. (114) Malmöhus and Skåne counties, Sweden. “Yes” versus “no” to question symptoms last 12 months  by direct standardization to county.
Adults: random sample by age deciles “Do you live close to a road with including dyspnea with or with-  Comparing subjects living close versus those not to living close 
20–59 yr. heavy trafﬁc?” out cough or wheeze; long- to heavy trafﬁc, asthma symptoms were more prevalent (10.5 
standing cough last year. vs. 8.4%, respectively; p = 0.001) and long-standing cough 
Physician-diagnosed illness: was also more prevalent (15.9 vs. 10.5%, respectively; 
asthma (self-reported). p = 0.001).
Logistic regressions on asthma diagnosis controlled for age, 
gender, and smoking behavior.
Asthma diagnosis was signiﬁcantly associated with living close 
to heavy trafﬁc [OR 1.29 (95% CI 1.02, 1.62)].
Wyler et al. Cross-sectional. Trafﬁc density on street of home Respiratory symptoms: hay fever Logistic regressions controlled for age, gender, smoking 
(113) Basel-Stadt, NW Switzerland. address: past 2 yr; ever symptoms of behavior, education, number of siblings, and family history of 
Trafﬁc “decimals” ranged from 24 to  Cars per 24 hr: 24–710;  seasonal rhinitis or conjunctivitis atopy.
32,504 vehicles/day. 711–1,620; 1,621–5,250;  when exposed to pollen; ever There were no associations between any respiratory symptoms 
Adults: 18–60 yr (mean 41.1); n = 820. 5,251–32,504 seasonal asthma symptoms of and trafﬁc density.
Known residence time at same address Trucks per 24 hr: 0–20, 21–100, cough or wheeze or chest Sensitization to pollen: ordinal comparisons to lowest car 
incorporated into analysis: 1–9 yr versus  101–360, 361–4,744. tightness or dyspnea when density showed a signiﬁcant trend, with larger effects for 
≥10 yr exposed to pollen. resident living in same home ≥10 yr: OR 1.99 (95% CI 0.91, 
Atopic sensitization: SPT for 4.38), OR 2.47 (95% CI 1.06, 5.73), OR 2.83 (95% CI 1.26, 6.31). 
local pollen (timothy grass, Effects were similar for truck trafﬁc. Effects were larger for 
birch, pellitory-of-the-wall),  women than men. 
dust mite, cat, dog, fungi (clad- Sensitization to indoor allergens (dust mite, cat, dog): no 
osporium, alternaria). signiﬁcant trends were found.
Abbreviations: BHR, bronchial hyperresponsiveness; ICD-9, International Classiﬁcation of Diseases, 9th Revision; ISAAC: International Study of Asthma and Allergies in Childhood; MEF,
maximal expiratory ﬂow rates when, as indicated by subscripts, 25%, 50%, or 75% of forced vital capacity has expired; PEFR, peak expiratory ﬂow rate; SPT, skin prick test; TAI, trafﬁc
activity index. study in Italy also found increased prevalence
of asthma and symptoms from truck and bus
trafﬁc but not overall trafﬁc (104). Only the
study by Wyler et al. (113) failed to show any
difference between truck and car traffic in
strengths of association; positive associations
were limited to atopic sensitization.
Although most of the traffic studies did
not report associations by gender, four did
ﬁnd adverse effects of trafﬁc-related exposures
in children to be stronger in girls than in boys
(99,102,103,115), while two other showed
null results for both genders (105,108). In
the study by Wyler et al. (113) in adults,
associations between pollen sensitization and
home traffic density were larger for women
than men. These gender differences are unex-
plained. Although differences in the percep-
tion of symptoms or reporting bias are
possible, this does not explain the consider-
ably larger lung function deficits in girls
reported by Brunekreef et al. (102). 
Negative results in the studies of traffic-
related exposures may be due to weaknesses
that lead to exposure and outcome misclassiﬁ-
cation, which generally, but not always, lead
to bias toward the null hypothesis if the mis-
classification is independent of systematic
errors (118). This bias was possible in studies
that used areawide exposure estimates with-
out assessments of microenvironmental expo-
sures or traffic near the home and school
(96,100,106,110), or that relied entirely or
partly on self-reported exposures (98,101,
104,107,114). Nevertheless, most of these
studies still showed positive associations
between traffic and respiratory outcomes.
Except for pulmonary function tests
(96,102,107,112) and tests for atopic sensiti-
zation (107,109,113), respiratory outcomes,
including physician-diagnosed illnesses, were
either abstracted from administrative data-
bases (97,99,105,108) or self-reported for the
remaining studies. All but a subsample of two
studies (110,112) were subject to cross-
sectional or case–control biases. One of these
biases stems from the use of current exposure.
Current exposure may not be a good surro-
gate for exposure during past times that are
more temporally relevant to current disease
status. This is because outcomes may have an
onset in the past, or because outcomes were
previous illnesses or exacerbations of disease
recalled in survey questionnaires. An impor-
tant assumption is that current residence near
trafﬁc is a proxy for past exposures, and some,
but not all, of the studies screened for resi-
dence times (96,99,102,103,107,109). One
resultant systematic bias that could lead to
null results is differential migration away
from busy streets by symptomatic subjects.
This is supported by the ﬁnding of Oosterlee
et al. (115) that parents with children having
respiratory symptoms live an average of 2.6
years shorter at the present address than those
of asymptomatic children. A positive bias, on
the other hand, could have occurred from
socioeconomic status (SES), which was not
always controlled for. This is important
because people living on busy streets may be
poorer. Clearly, well-designed prospective
cohort studies and repeated measures panel
studies are needed to assess the question of
whether exposure to primary pollutants from
traffic, which include air toxics, are risk fac-
tors for the onset or exacerbation of asthma
and other respiratory allergic illnesses in
children and adults.
One epidemiologic approach that may
prove useful to deﬁne source-speciﬁc air pol-
lutant exposures such as trafﬁc-related expo-
sures is the use of principal component factor
analysis with varimax rotation using available
criteria pollutant data. One large survey study
used this approach in Taiwan (106). They
recruited 331,686 middle school children
who were nonsmokers and were enrolled in
schools within 2 km of 1 of 55 monitoring
stations. They compared asthma prevalence
rates with air pollution concentrations and
found positive associations with asthma
prevalence for NOx and CO. These gases had
factor loadings (correlation of a variable with
a factor, which is a latent, unobserved vari-
able) over 0.91, along with inverse loadings
for O3 of –0.92, likely from scavenging of O3
by NOx (Table 2). For an interquartile
increase in CO (326 ppb) and in NOx (17.3
ppb), the prevalence of either physician-
diagnosed or questionnaire-based asthma
increased around 1% for both boys and girls.
Asthma was not associated with PM10 or
SO2, except for an unexpected inverse associ-
ation in boys for PM10. The association of
acute asthma with CO is supported in a
Seattle panel study of 133 asthmatic children
and is likely explained by more causal compo-
nents of vehicle exhaust and other combus-
tion byproducts (119).
It is possible that associations between
allergic respiratory illnesses and trafﬁc density
are due to NAAQS criteria air pollutants, par-
ticularly NO2, which is directly related to
local trafﬁc density (120). Krämer et al. (109)
assessed this possibility in a study of 306 chil-
dren 9 years of age living at least 2 years in a
home near major roads in Germany
(Table 2). Using passive samples with Palmes
tubes, weekly average concentrations were
measured for personal NO2 in March and
September, and for outdoor home or near-
home NO2 at 158 locations in each of four
seasons (levels at home addresses were inter-
polated). Investigators showed that outdoor
NO2 was a good predictor of home traffic
density (Pearson r, 0.70) but a poor predictor
for personal NO2 exposure (r, 0.37) reﬂecting
the known importance of indoor NO2
sources. They followed the children with
weekly parental questionnaires for atopic
symptoms for 1 year. In suburban areas there
was little variation in outdoor NO2, (range
43–46 µg/m3) and inclusion of suburban
subjects (n = 104) in regression models
decreased parameter estimates and increased
standard errors. For urban areas (n = 202),
they found that atopic sensitizations to
pollen, to house dust mite or cat, and to milk
or egg (by SPTs or RAST) were each signiﬁ-
cantly associated with outdoor NO2 (ORs
ranged from 3.5 to 5.0) but not predicted
personal NO2. They also found that outdoor
NO2, but not predicted personal NO2, was
signiﬁcantly associated with reports of at least
1 week with symptoms of wheezing and of
allergic rhinitis. Relationships for atopy and
rhinitis symptoms by quartile of outdoor
NO2 suggested a dose–response relationship
(Figure 2). Although an ever diagnosis of hay
fever (n = 35) was associated with outdoor
NO2, diagnosed asthma was not (n = 25).
The maximum outdoor NO2 of the urban
sites was 36 ppb (67.5 µg/m3), which is far
less than the U.S. EPA NAAQS of 53 ppb
annual mean (100 µg/m3). The overall results
suggest that outdoor NO2 was serving as a
marker for more causal airborne agents rather
than a direct effect of NO2. 
High personal exposures to PAHs near
busy streets were possible in the study by
Krämer et al. (109), as well as other studies in
Table 2 for high trafﬁc density. Dubowsky et
al. (121) measured total real-time, particle-
bound PAHs from three nonsmoking indoor
sites with different trafﬁc densities character-
istic of urban, semiurban, and suburban resi-
dencies. Diaries were used to detect effects of
cooking and indoor combustion events (e.g.,
candles). A signiﬁcant contribution of trafﬁc-
related PAHs to indoor PAHs was detected.
Indoor peaks occurred during morning rush
hour on weekdays only (max = 65 ng/m3 for
urban locations). The geometric means of
PAHs corrected for indoor sources were
urban, 31 ng/m3; semiurban, 19 ng/m3; and
suburban, 8 ng/m3. 
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Figure 2. Relationship of symptoms of allergic rhini-
tis ( ) and of atopic sensitization against pollen
( ) to quartiles of exposure to outdoor home NO2
in 202 children 9 years of age living in urban areas
of Germany. Adapted from Krämer et al. (109).
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Düsseltal
FriedrichstadtDespite the suggestion that NO2 may be
acting as a surrogate pollutant, the respiratory
effects of NO2 are still important. However,
the magnitudes of effects of NO2 on asthma
are not entirely clear, and there are consider-
able inconsistencies in the experimental litera-
ture. Some studies have shown alterations in
lung function, airway responsiveness, or
symptoms, whereas others have not, even at
high concentrations [reviewed by Bascom et
al. (5)]. Data that support the trafﬁc density
studies come from a clinical crossover study
that used ambient exposures of 20 mild
pollen-allergic adult asthmatic individuals
(122). Subjects showed early- and late-phase
bronchospastic reactions to pollen allergen
challenge that were greater 4 hr after a 30-min
exposure in a car parked in a road tunnel
(30-min median NO2, 157 ppb; median
PM2.5, 95 µg/m3) compared with a low con-
trol exposure in a suburban hotel (24-hr badge
NO2, 22 ppb). Specific airway resistance 15
min after allergen challenge increased 44% in
12 subjects exposed to road tunnel NO2 >
159 ppb compared with 24% for their control
exposures (p < 0.05). The higher NO2 tunnel
exposures were associated with significantly
more symptoms and beta-agonist inhaler use
18 hr after allergen challenge. In addition,
FEV1 decreased signiﬁcantly more than with
control exposures 3–10 hr after allergen chal-
lenge (8.5 vs. 6.8%). Effects were smaller
using PM10 or PM2.5 as the exposure metric.
The authors compared their results with those
from earlier chamber studies using 265 ppb
NO2 before allergen challenge. They con-
cluded that although those results also showed
an enhancement of early- and late-phase asth-
matic reactions (123,124), effects were greater
for lower NO2 exposures in the tunnel,
suggesting other pollutants were important. 
Other agents aside from either NAAQS
criteria air pollutants or air toxics could
explain some part of the association of asthma
and allergy outcomes with traffic density.
Latex allergen found on respirable rubber tire
particles is likely common in urban air
(125,126) and could lead to sensitization and
respiratory symptoms. In addition, the physi-
cal action of motor vehicles on road dust,
which is known to contain pollen grains,
could lead to the production and resuspen-
sion of smaller respirable pollen fragments
(37). Other allergenic bioaerosols such as fun-
gal spores could be fragmented and resus-
pended as well. Interactions between
pollutants and allergens could also inﬂuence
effects. Allergenic molecules could be deliv-
ered to target sites in the airways on diesel
carbon particles. as evidenced in vitro using
the rye grass pollen allergen Lol p1 (127).
Another study using immunogold labeling
techniques found that indoor home soot par-
ticles, primarily in the submicrometer size
range, had bound antigens of cat (Fel d 1),
dog (Can f 1), and birch pollen (Bet v 1),
and this adsorption was replicated in vitro
with DEP particles (128). Other biologic
interactions between pollutants and allergens
on airways that favor inﬂammatory reactions
have been hypothesized (129), including
enhancement of allergen sensitization in
asthmatic children with ETS exposure (130)
and pollutant-induced enhancements of the
antigenicity of allergens (131,132).
Summary of the Potential Role
of PAHs in Asthma
Experimental evidence supports the biologic
plausibility of a role for PAHs from fossil
fuel combustion products in the onset and
exacerbation of asthma. However, the occu-
pational data on DE and asthma onset are
limited to one three-case series. In addition,
despite high exposures, overall inconsistency
is found in occupational studies of respira-
tory symptoms or lung function and
diesel/gas exhaust exposures. Bias from the
healthy worker effect is likely given the
expectation of avoidance behavior among
individuals with respiratory sensitivity to
inhaled irritants, including asthmatics. This
behavior has been hypothesized to result
from a toxicant-induced loss of tolerance
(133). The inconsistent and weak occupa-
tional evidence does not rule out different
dose–response relationships for asthma in
nonoccupational settings. Epidemiologic
results showing associations between child-
hood asthma and ETS may be explained, in
part, by PAHs. Positive results in epidemio-
logic studies of asthma and traffic-related
exposures also may be explained, in part, by
PAHs. The question that remains is, what
are the determinants of asthma associations
with complex mixtures of ETS-related and
trafﬁc-related particle components and gases? 
Coherence with Trafﬁc Studies
by Trends in Asthma and
Urbanization 
The above review gives the overall impression
that asthma, related respiratory symptoms,
lung function deficits, and atopy are higher
among people living near busy trafﬁc. Some
data coherent with this view are found in
studies showing a higher prevalence of asthma
and atopic conditions in more developed
Westernized countries and in urban com-
pared with rural areas [reviewed by Beasley et
al. (134) and Weinberg (135)]. For instance,
studies in Africa have shown that pediatric
asthma is rare in rural regions, whereas
African children living in urban areas have
experienced an increasing incidence of
asthma (135). The urban-rural differences
have tended to narrow as rural Africans
became more Westernized (135). This
suggests that the increase of asthma seen in
developed countries may be attributable to
some component(s) of urbanization, includ-
ing automobile and truck traffic. However,
this urbanization gradient is not a consistent
finding across the literature (136). For
instance, in the traffic exposure–response
study by Montnémery et al. (114) (Table 2),
although there were signiﬁcant associations of
asthma symptoms and diagnosis to traffic
density, there were no urban-rural differ-
ences. In addition, some recent studies that
speciﬁcally examined farming environments,
found a decreased risk of asthma and atopy
among children living on farms (137,138),
particularly where there is regular contact
with farm animals. This prompted these
investigators to hypothesize that a “protective
farm factor” may reflect the influence of
microbial agents on TH1 versus TH2 cell
development or reflect the development of
immunotolerance (137,138). This possibil-
ity, in addition to potentially high levels of
confounding by uncontrolled factors that
vary by geography, makes it difficult to
clearly interpret the cross-sectional studies on
urban versus rural areas or ecologic studies of
international differences.
Formaldehyde, Asthma, and
Atopy in Children
The following section will examine the epi-
demiologic literature on the relationship of
asthma and atopy in children to formalde-
hyde. This serves to exemplify one of the few
low molecular weight agents associated with
asthma in both the occupational (22) and
nonoccupational literature, and to exemplify
an air toxic that has effects from low to high
exposure levels. However, there are little
available nonoccupational data on the risk of
asthma onset from formaldehyde.
One study passively measured formalde-
hyde over 2 weeks in the homes of 298 chil-
dren and 613 adults (139). In log-linear
models controlling for SES variables and eth-
nicity, the study found a signiﬁcantly higher
prevalence of physician-diagnosed asthma
and chronic bronchitis in children 6–15 years
of age living in homes with higher formalde-
hyde concentrations over 41 ppb (six asthma
and six bronchitis cases). However, the room-
speciﬁc measurements revealed that the asso-
ciation was attributable to high formaldehyde
concentrations (>60 ppb) in kitchens, partic-
ularly those homes with ETS exposures (ﬁve
asthma cases, ﬁve bronchitis cases), suggesting
possible confounding by other factors not
measured. In random effects models control-
ling for SES and ETS, they found signiﬁcant
inverse associations between morning PEF
rates and average formaldehyde from the bed-
room, and between evening PEF and house-
hold average formaldehyde. There was no
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was independent of ETS, but the effects of
age or of anthropomorphic factors were not
mentioned. Symptoms of chronic cough and
wheeze were higher, and PEF lower, in adults
living in houses with higher formaldehyde
levels. There was a significant interaction
between formaldehyde and tobacco smoking
in relation to cough in adults. Passive mea-
surements of NO2 did not confound the
associations in children or adults.
Other nonoccupational data on formalde-
hyde relate indirectly to asthma. Wantke et al.
(140) evaluated levels of specific IgE to
formaldehyde using RAST in 62 eight-year-
old children attending (for 2.5 years) one
school with particleboard paneling and urea
foam window framing. The children were
transferred to a brick building (23–29 ppb
formaldehyde) because of elevated formalde-
hyde levels in particleboard classrooms (43–75
ppb) and complaints of headache, cough,
rhinitis, and nosebleeds. Symptoms and spe-
ciﬁc IgE were examined before and 3 months
after cessation of exposure. At baseline, three
children had RAST classes ≥ 2 (positive) and
21 had classes ≥ 1.3 (elevated), whereas all 19
control children attending another school had
classes < 1.3. After transfer, the RAST classes
signiﬁcantly decreased from 1.7 ± 0.5 to 1.2 ±
0.2 (p < 0.002), and symptoms decreased.
However, IgE levels did not correlate with
symptoms. None of the children had asthma.
Garrett et al. (141) hypothesized that
formaldehyde may adversely affect the lower
respiratory tract by increasing the risk of aller-
gic sensitization to common allergens. They
studied 43 homes with at least one asthmatic
child (53 asthmatic, 30 nonasthmatic) and 37
homes with only nonasthmatic children (n =
65). Atopy was evaluated in the children
(7–14 years of age) with SPTs for allergy to
12 common animal, fungal, and pollen aller-
gens. Formaldehyde was measured passively
throughout the homes over 4 days in four dif-
ferent times of 1 year. Atopic sensitization by
SPT was associated with formaldehyde levels
[OR for 20 µg/m3 increase, 1.42 (95% CI
0.99–2.04)]. Across three formaldehyde
exposure categories, there was also a signifi-
cant increase in the number of positive SPTs
and in the wheal ratio of allergen SPT over
histamine SPT. Mean respiratory symptom
scores were signiﬁcantly and positively associ-
ated across the three categories. There was a
significant positive association between par-
ent-reported, physician-diagnosed asthma
and formaldehyde, but this was confounded
by history of parental asthma and parental
allergy. It is unclear why these familial deter-
minants were treated as confounders rather
than effect modiﬁers, although knowledge of
asthma by parents may lead to bias in the
assessment of asthma in their children. 
Several other studies of nonasthmatic
subjects have examined health outcomes and
biomarkers that are relevant to asthma.
Franklin et al. (142) studied 224 children
6–13 years of age with no history of upper or
lower respiratory tract diseases, using expired
nitric oxide (eNO) as a marker for lower air-
way inﬂammation (143). Formaldehyde was
passively monitored in the children’s homes
for 3–4 days. Maximum end expiratory eNO
was measured in each child with a fast-
response chemiluminescence analyzer. They
found no effect of formaldehyde on lung
function. However, controlling for age and
atopy (by SPT), eNO was significantly ele-
vated to 15.5 ppb (95% CI 10.5, 22.9) in
homes with ≥ 50 ppb formaldehyde com-
pared with 8.7 ppb eNO (95% CI 7.9, 9.6)
in homes with < 50 ppb formaldehyde.
Authors did not report the cross-sectional risk
of atopy to common allergens from exposure
to formaldehyde. They hypothesized that
formaldehyde causes inflammation and the
release of cytokines, which leads to the upreg-
ulation of inducible NO synthetase. This
view was supported by another study that
found intranasal exposure to 400 ppb
formaldehyde in healthy subjects caused
eosinophilia in the nasal epithelium (144). 
Given that a key marker of the asthmo-
genic effects of formaldehyde may be speciﬁc
IgE to formaldehyde-albumin, other air toxics
could be similarly screened to evaluate their
potential inﬂuence on atopic responses. 
Experimental Evidence 
for VOC Mixtures 
Some experimental evidence in controlled
human exposure studies supports an respira-
tory irritant mechanism for VOCs (145,146),
but the human experimental research on
lower respiratory or pulmonary immunologic
effects of VOCs is scarce apart from studies of
agents associated with occupational asthma
(e.g., TDI, formaldehyde). 
Koren et al. (146) conducted a random-
ized crossover chamber study of 14 healthy
nonsmoking young adult men. Subjects were
exposed for 4 hr 1 week apart to clean air and
25 µg/m3 of a VOC mixture typical of indoor
nonindustrial microenvironments. Nasal
lavage performed immediately after exposure
and 18 hr later showed signiﬁcant increases in
neutrophils at both time points. Harving et
al. (147) conducted a randomized crossover
chamber study of 11 asthmatic individuals
who were hyperreactive to histamine.
Subjects were exposed for 90 min, 1 week
apart to clean air and VOC mixtures at 2.5
and 25 µg/m3. Investigators found FEV1
decreased to 91% of baseline with 25 µg/m3,
but this was not significantly different from
sham exposure, and there was no change in
histamine reactivity. It is possible that the
null results do not reflect inflammatory
changes that influence small airways, which
could be missed with FEV1 measurements.
What may be occurring in natural environ-
ments is another story, with mixed expo-
sures possibly interacting under a wide range
of exposure–dose conditions. This is best
investigated with epidemiologic designs.
Epidemiologic Evidence 
for VOC Mixtures 
Indirect evidence of a role for ambient VOCs
in asthma comes from research linking a
buildup of indoor irritants including VOCs
and bioaerosols in ofﬁce buildings to a non-
specific cluster of symptoms called the “sick
building syndrome,” which includes upper
and lower respiratory tract symptoms, eye
irritation, headache, and fatigue. Other stud-
ies have also found new-onset asthma occur-
ring in relation to particular nonresidential
indoor environments, especially where prob-
lems with ventilation systems or dampness
have been found (75). It is possible that fun-
gal spores or other aeroallergens, mycotoxins,
and endotoxins could increase in parallel with
VOCs under conditions of inadequate air
exchange at work, and be responsible for
some of these ﬁndings.
Epidemiologic evidence linking indoor
home VOCs with asthma or related respira-
tory outcomes come largely from cross-sec-
tional studies. A survey of 627 students
13–14 years of age attending 11 schools in
Uppsala, Sweden, showed self-reported
asthma prevalence (n = 40) was higher in
schools with higher VOCs (148). Other risk
factors (e.g., aeroallergens) were not con-
trolled for in this association. In addition,
passive, not active, VOC measurements were
associated with asthma. 
Norbäck et al. (149), using a survey sam-
ple of 600 adults 20–44 years of age in
Uppsala, Sweden, selected a nonrandom sub-
sample of 47 subjects reporting asthma
attacks or nocturnal breathlessness the last 12
months or reporting current use of asthma
medications. A random subsample of 41
other subjects was selected from the survey
pool with negative responses. Logistic regres-
sion models adjusted for age, sex, smoking,
carpeting, and house dust mites, but not
dampness, which was signiﬁcant. There were
no effects on daytime breathlessness from
concentrations of 2-hr active VOC samples in
the homes. Nocturnal breathlessness was
associated with toluene, C8-aromatics, ter-
penes, and formaldehyde in adjusted models.
Bronchial hyperresponsiveness was correlated
only with limonene. PEF variability was
correlated only with terpenes. 
Wieslander et al. (150) aimed to examine
respiratory symptoms and asthma outcomes
in relation to indoor paint exposures in the
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sample of 562 adult subjects, including
asymptomatic responders along with all
reporting asthma or nocturnal dyspnea (216
subjects), using the same survey source popu-
lation as Norbäck et al. (149) in Uppsala.
Asthma was defined as positive bronchial
hyperresponsiveness to methacholine plus
asthma symptoms (99 subjects). Thirty-two
percent of homes and 23% of workplaces
were painted within the last year. Total
VOC was elevated by 100 µg/m3 in 62
newly painted homes. Logistic regression
models adjusted for age, sex, and current
smoking but not ETS. Asthma prevalence
was greater for newly painted homes [OR 1.5
(95% CI 1.0–2.4)], consistent with greater
differences in VOCs (especially 2,2,4-
trimethyl 1,3-pentanediol diisobutyrate and
formaldehyde). Blood eosinophil concentra-
tions were also elevated in newly painted
homes. In newly painted workplaces, asth-
malike symptoms were signiﬁcantly increased
(wheeze, dyspnea), but there was no associa-
tion with bronchial hyperresponsiveness or
eosinophils. There were no associations for
newly painted homes or workplaces and
atopy (SPT), serum eosinophilic cationic
protein, serum IgE, PEF variability (1 week,
self-administered, twice daily), or in-clinic
FEV1. Biases in the above cross-sectional
studies in Uppsala include potential selection
bias and the possibility that health outcomes
preceded exposures.
Diez et al. (151) studied 266 newborn
children born with birth weight of
1,500–2,500 g, or with elevated IgE in cord
blood, or with a positive primary family his-
tory of atopic disease. Concentrations of 25
VOCs were monitored indoors during the
first 4 weeks of life. Parents filled out ques-
tionnaires after 6 weeks and 1 year of age.
Postnatal respiratory infections were associ-
ated with benzene > 5.6 µg/m3 [OR 2.4
(95% CI 1.3, 4.5)] and styrene > 2.0 µg/m3
[OR 2.1 (95% CI 1.1, 4.2)]. Wheezing was
associated with reports of restoration (includ-
ing painting and installation of carpeting)
during the ﬁrst year of life, but not with total
or specific IgE at the age of 1 year. These
models controlled for heating, gas cooking,
home size, new furniture, and animals but
did not control for signiﬁcant effects of ETS,
which was correlated with benzene. 
All of the above studies of indoor VOCs
may be subject to unmeasured confounding
by other causal agents that increase indoors
under low ventilation conditions, including
aeroallergens, or that are correlated with
VOCs for other reasons. Most, but not all, of
the studies controlled for ETS. The research
to date is too sparse to evaluate causality from
indoor home VOCs, but there is even less
information to evaluate the public health
impact on respiratory health from outdoor
VOCs, which include some of the same
compounds found indoors.
Ware et al. (152) conducted a study in a
large chemical manufacturing center in the
Kanawha Valley, West Virginia. They sur-
veyed 74 elementary schools with interviews
of 8,549 children in and out of the valley and
measured passive 8-week samples of 5 petro-
leum-related VOCs (toluene, m,p-xylene,
benzene, o-xylene, decane) and 10 process-
related VOCs (1,1,1-trichloroethane, carbon
tetrachloride, 1-butanol, chloroform, per-
chloroethylene, methyl isobutyl ketone, 1,2-
dichloroethane, styrene, mesityl oxide,
2-ethoxyethyl acetate). Higher VOC concen-
trations were found in the valley. Cross-sec-
tional results showed children in the valley
had higher rates of physician-diagnosed
asthma [OR 1.27 (95% CI 1.09, 1.48)].
Composite indicators for lower respiratory
symptoms in the last year were weakly posi-
tively associated with petroleum-related VOC
levels [OR per 10 µg/m3, 1.05 (95% CI 1.02,
1.07)] and process-related VOCs levels [OR
per 2 µg/m3, 1.08 (95% CI 1.02, 1.14)].
Asthma diagnoses were weakly positively
associated with petroleum-related VOCs [OR
1.05 (95% CI 1.02, 1.08)] but not process-
related VOCs (OR 0.99). One school with
high petroleum-related VOCs strongly inﬂu-
enced the model. The average concentrations
measured in the Kanawha study do not differ
greatly from average levels in large urban areas
(68). For the Kanawha study compared with a
Los Angeles ambient exposure study, for
example, average toluene was 9.7 µg/m3 ver-
sus 13 µg/m3, respectively, and for benzene,
3.2 µg/m3 versus 3.5 µg/m3, respectively
(153). In a study of 51 residents of Los
Angeles, personal and indoor air concentra-
tions of all prevalent VOCs except carbon
tetrachloride were higher than outdoor ambi-
ent concentrations (154). Also, personal real-
time exposures can be even higher, particularly
while in cars (155). For example, measure-
ments of toluene taken inside cars in New
York City ranged from 26 to 56 µg/m3 and for
benzene ranged from 9 to 11 µg/m3 (156). 
Conclusions
Considerable progress has been made in iden-
tifying risks to asthma morbidity from the
major criteria air pollutants such as ambient
O3 and particle mass, as well as from major
types of air pollutant mixtures, particularly
ETS. Like ambient particle mass though, the
causal components of ETS are poorly under-
stood. Less is known about asthma risks from
primary emissions linked to car and truck
trafﬁc, which compared with ETS may be an
equally important mixed-pollutant exposure.
Both ETS and trafﬁc exhaust pollutants con-
tain some of the same toxic air pollutants,
including PAHs. Experimental data support
the biologic plausibility of a role of PAHs in
allergic respiratory responses. However, the
occupational epidemiology literature on res-
piratory outcomes and exposures to diesel and
automobile emissions is inconsistent, likely
due to major methodologic flaws. The
nonoccupational epidemiology literature on
trafﬁc-related exposures, on the other hand, is
more consistent, particularly when better-
designed studies are considered. These studies
commonly showed an increase in the preva-
lence of asthma, atopy, upper and lower res-
piratory symptoms, and lung function deﬁcits
in relation to higher exposures to traffic
(Table 2). Other air toxics commonly
encountered in both indoor and outdoor
ambient air include a large number of VOCs,
including a known occupational asthmogen,
formaldehyde. At present, however, both the
human experimental and epidemiologic liter-
ature is limited to a few studies. What is
needed now is to advance epidemiologic
research on relationships of asthma onset and
exacerbation to air toxics exposures. It will be
important to disentangle effects of air toxics
from major air pollutants regularly monitored
by governments such as particle mass, black
smoke, or NO2. Studies could focus on air
toxics identified as asthmogenic in occupa-
tional studies (e.g., certain metal compounds)
and on other air toxics expected to have
adverse respiratory effects based on biologic
mechanisms (e.g., PAHs). Studies most likely
to yield clear and valuable information
include well-designed prospective cohort
studies to ascertain the relevance of air toxics
to asthma onset and chronicity, and repeated
measures studies to evaluate acute exposure-
dose–response relationships in susceptible
individuals. Key design issues that have been
only partly addressed to date include accurate
exposure assessments, including personal and
microenvironmental components, and accu-
rate outcome assessments, including validated
and objective physiologic measurements of
acute and chronic ill health outcomes.
Despite limitations in the current state of
knowledge about air toxics and asthma, this
review gives sufficient evidence to justify
more intensive investigation.
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